About Bonnie Doran

I'm a writer. My heart is in science fiction, but I sold sixty-seven devotions before I wrote novels. My debut novel, a science thriller entitled Dark Biology, was published with Harbourlight, an imprint of Pelican Book Group. I'm also a cancer survivor, diagnosed with malignant melanoma in 2014. I am currently working on a devotional book for cancer survivors. When I'm not writing, I enjoy reading, old sci-fi movies, cooking, Sudoku puzzles, Scrabble, and hanging out with writers and sci-fi fans. I have a reputation for telling groan-producing puns. I've been married 35 years to John, an electrical engineer and Mad Scientist who plays with lasers for a living. We are owned by two Siamese cats.

Cancer Action Network

The Cancer Action Network (ACS CAN) is the advocacy arm of the American Cancer Society. It unites and empowers cancer patients, survivors, caregivers, and their families by helping them make their voices heard in the halls of government.

American Cancer Society
ACS CAN educates the public, lawmakers, candidates, and the media about the importance of the government’s role in defeating cancer.

The organization publishes non-partisan voter guides. Their candidate forums put lawmakers and candidates on the record to ensure they are accountable for their positions on cancer issues.

It presses lawmakers and candidates to support laws and policies that strengthen the fight against cancer.

Through its efforts, ACS CAN has obtained legislative victories in securing more cancer research dollars, expanding access to early detection, prevention, and treatment; and reducing suffering and death from tobacco.

To learn more or to join, visit http://www.acscan.org or call 1-888-NOW I CAN.

 

The Genesis of Immunotherapy

ImmunotherapyImmunotherapy is a new kid on the block in terms of cancer treatment. Traditional treatment includes surgery, radiation, chemotherapy, and hormonal treatments.

Two researchers worked on ways that a patient’s immune system could be unleashed to attack cancer. These breakthroughs led to an entirely new class of drugs, resulting in lasting remissions to many patients who had run out of options.

The two researchers, James P. Allison of the United States and Tasuku Honjo of Japan, worked independently and have both been awarded the Nobel Prize in Physiology or Medicine for this year.

T-cells, a type of white blood cell, are deployed to fight infections and cancer. The T-cells carry molecules called checkpoints that the body uses to shut down the cells when they need to stop. Cancer cells can lock onto these checkpoints, preventing the T-cells from fighting the disease.

The researchers identified two checkpoints which led to the development of drugs that would keep the checkpoints from working. In other words, the new drugs take the brakes off the immune system.

My oncologist told me, “Everything changed in 2011.” That’s when the first immunotherapy drug was approved by the FDA. Up until that point, the survival rate for melanoma patients was six to nine months. With the new drugs, a patient can expect to live for ten to twelve years.

Three of the drugs that resulted from this research were Yervoy, Opdivo, and Keytruda. These drugs are used for cancers of the lung, kidney, bladder, head and neck; for aggressive skin cancer melanoma; and for Hodgkin lymphoma among others.

President Jimmy Carter received Keytruda in 2015 when melanoma had spread to his brain and liver. He is now in remission.

Because of the way the immunotherapy drugs work, they can be too effective and turn the immune system against the patient’s own body.

I took two of these drugs during the course of my treatment. Yervoy caused serious side effects and had to be discontinued after two doses. Keytruda had practically no side effects and brought me remission from skin cancer melanoma after one year.

Needless to say, I’m grateful for the amazing discoveries that Drs. Honjo, Allison, and others have achieved. Who knows what’s on the horizon for the next generation?

 

 

 

 

 

 

Raising Money for Cancer Research

 

breast cancer month

Here are some unusual ways that organizations are raising money for cancer research:

Whoops! Bakery is dyeing all 21 flavors of its macarons pink from October 19 to 21. For each box of macarons sold that weekend (and all macarons sold online in October), Whoops! will donate $1 to the National Breast Cancer Foundation. Website is http://www.bywhoops.com.

And look in May for Speed Rack USA, the all-female speed-bartending competition. One hundred percent of proceeds from the events in various cities goes to breast education, prevention, and research. Website is http://www.speedrack.net.

 

Pancreatic cancerSpeaking of May, there is a month-long celebration of Gamay wine which raises money for pancreatic cancer research. Max Kuller began Ga May in 2015 as a tribute to his father, who passed away from pancreatic cancer. Restaurants, wine retailers, distributors, and vintners in the Washington DC area raised $15,000 in 2015 for the Lustgarten Foundation to Cure Pancreatic Cancer. Website is http://www.lustgarten.org.

Where did I learn this information? From Wine Enthusiast and Food Network magazines. Who knew?